Trial Profile
A real world retrospective chart review in patients with diabetic macular edema receiving ILUVIEN®
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2021
Price :
$35
*
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions
- Acronyms USER
- 13 Sep 2018 According to an Alimera Sciences media release, data from this study will be presented at the 2018 Annual Meeting of the Retina Society (Sep 2018).
- 08 Nov 2017 According to an Alimera Sciences media release, updated data from this trial will be presented at 2017 Annual Meeting of the American Academy of Ophthalmology (AAO).
- 07 Nov 2017 According to an Alimera Sciences media release, data from this trial will be presented at the Ophthalmology Innovation Summit (OIS) 2017.